Inmode Ltd. Stock Price, News & Analysis

InMode Ltd. (Nasdaq: INMD) reported record revenues of $113.5 million for Q2 2022, marking a 30% increase year-over-year. The company's GAAP net income rose to $44.0 million, with earnings per diluted share at $0.52. Non-GAAP net income reached $50.4 million, translating to $0.59 per diluted share. The company expects 2022 revenues of $425 million to $435 million and a non-GAAP gross margin between 83% and 85%. InMode also received Health Canada's endorsement for its EmpowerRF platform.

InMode Ltd. (NASDAQ: INMD) announced that CFO Yair Malca will present at the Canaccord 42nd Annual Growth Conference on August 11, 2022, at 3:30 PM ET, in Boston. The presentation will be available via webcast on the company's Investor Relations website. Malca is also scheduled for one-on-one meetings with investors on August 10 and August 11. InMode specializes in innovative medical technologies, focusing on minimally invasive RF procedures in various medical fields.

InMode Ltd. (INMD) announced expectations for record financial results in Q2 2022, forecasting revenue between $113.0 million to $113.3 million. The company anticipates a non-GAAP earnings per diluted share of $0.57 to $0.58. Additionally, InMode raised its full-year revenue guidance to a range of $425 million to $435 million, up from a previous range of $415 million to $425 million. The company attributes this growth to strong demand for its medical technologies in aesthetic surgery.

InMode Ltd. (Nasdaq: INMD) has launched the EmpowerRF Women's Wellness technology in Canada after receiving certification from Health Canada. This advancement aims to improve urinary incontinence symptoms (SUI) and builds upon existing licenses for Genitourinary Syndrome of Menopause (GSM) and chronic pelvic pain. The EmpowerRF platform offers advanced therapies, including intravaginal electrical muscle stimulation and bipolar radiofrequency. InMode emphasizes its commitment to enhancing women's health through effective, minimally invasive solutions. This initiative reflects a strategic milestone for InMode in the global healthcare market.

InMode Ltd. (Nasdaq: INMD), a prominent global provider of innovative medical technologies, announced participation in the UBS Healthcare One-on-One Virtual Day on June 1, 2022. CEO Moshe Mizrahy and CFO Yair Malca will represent the company. Interested parties can schedule meetings through their UBS representative or by contacting Miri Segal at msegal@ms-ir.com. InMode specializes in medical devices using radiofrequency technology, serving various medical fields including plastic surgery and dermatology.

InMode Ltd. (NASDAQ: INMD) reported Q1 2022 revenues of $85.9 million, a 31% year-over-year increase. GAAP net income was $31 million, reflecting a 16% rise from the prior year, achieving GAAP diluted EPS of $0.36. The company noted record consumable revenues of $14 million, up 79% year-over-year. Despite facing global supply chain challenges affecting gross margins, management reiterated a full-year revenue guidance of $415-$425 million and robust long-term gross margin targets of 84%-86%.

InMode Ltd (Nasdaq: INMD) announced its expected financial results for Q1 2022, projecting revenue between $85.0 million and $85.5 million and non-GAAP earnings per diluted share between $0.38 and $0.39. The company noted an 83% to 84% gross margin, reflecting growth in demand for its minimally invasive solutions. Despite challenges from COVID-19 variants and supply chain issues, InMode managed to maintain productivity and meet delivery expectations. A conference call is scheduled for May 2, 2022, to discuss the results further.

InMode Ltd. (Nasdaq: INMD), a leading provider of innovative medical technologies, will participate in a virtual fireside chat at the 21st Annual Needham Healthcare Conference on April 14, 2022, at 4:30 p.m. ET. The event will feature CEO Moshe Mizrahy, CFO Yair Malca, and CMO Dr. Spero Theodorou, hosted by CFA Mike Matson. Management will also hold one-on-one meetings that day. A live link for the chat is available here, with more info on InMode's investor relations site.

InMode Ltd. (Nasdaq: INMD) announced a new share repurchase program, approving the buyback of up to 1 million ordinary shares. This decision follows the successful completion of a previous buyback in September 2020, reflecting the company's confidence in its long-term outlook. The program, funded by available cash, aims to enhance shareholder value and follows a trend of fiscally responsible investments. The board emphasized strong cash flow and a robust balance sheet as key factors justifying the buyback.